161 related articles for article (PubMed ID: 31639617)
1. Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation.
Liu ZN; Jia WQ; Jiang T; Dai JW; Shuai C; Lv XW
Int Immunopharmacol; 2019 Dec; 77():105915. PubMed ID: 31639617
[TBL] [Abstract][Full Text] [Related]
2. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
3. The mechanism by which ATP regulates alcoholic steatohepatitis through P2X4 and CD39.
Xia GQ; Cai JN; Wu X; Fang Q; Zhao N; Lv XW
Eur J Pharmacol; 2022 Feb; 916():174729. PubMed ID: 34973190
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the P2Y2 Receptor Attenuates Alcoholic Liver Inflammation by Targeting the EGFR-ERK1/2 Signaling Pathway.
Liu ZN; Su QQ; Wang YH; Wu X; Lv XW
Drug Des Devel Ther; 2022; 16():1107-1120. PubMed ID: 35444406
[TBL] [Abstract][Full Text] [Related]
5. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease.
Shuai C; Xia GQ; Yuan F; Wang S; Lv XW
Eur J Pharmacol; 2021 Aug; 905():174198. PubMed ID: 34033815
[TBL] [Abstract][Full Text] [Related]
6. Extracellular ATP and Purinergic P2Y
Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
[TBL] [Abstract][Full Text] [Related]
7. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
Jin H; Ko YS; Kim HJ
Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
[TBL] [Abstract][Full Text] [Related]
8. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
9. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
10. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
[TBL] [Abstract][Full Text] [Related]
11. The P2Y
Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI
Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380
[TBL] [Abstract][Full Text] [Related]
12. Activation of the P2Y
Orriss IR; Guneri D; Hajjawi MOR; Shaw K; Patel JJ; Arnett TR
J Endocrinol; 2017 Jun; 233(3):341-356. PubMed ID: 28420708
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice.
Iracheta-Vellve A; Petrasek J; Satishchandran A; Gyongyosi B; Saha B; Kodys K; Fitzgerald KA; Kurt-Jones EA; Szabo G
J Hepatol; 2015 Nov; 63(5):1147-55. PubMed ID: 26100496
[TBL] [Abstract][Full Text] [Related]
14. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
15. Epithelial miR-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma.
Zhang K; Feng Y; Liang Y; Wu W; Chang C; Chen D; Chen S; Gao J; Chen G; Yi L; Cheng D; Zhen G
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33945508
[TBL] [Abstract][Full Text] [Related]
16. Deletion of cd39/entpd1 results in hepatic insulin resistance.
Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
[TBL] [Abstract][Full Text] [Related]
17. P2Y
Jin H; Ko YS; Park SW; Kim HJ
Free Radic Biol Med; 2019 May; 136():109-117. PubMed ID: 30959169
[TBL] [Abstract][Full Text] [Related]
18. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.
Xie R; Xu J; Wen G; Jin H; Liu X; Yang Y; Ji B; Jiang Y; Song P; Dong H; Tuo B
J Biol Chem; 2014 Jul; 289(27):19137-49. PubMed ID: 24847054
[TBL] [Abstract][Full Text] [Related]
19. CD39 improves survival in microbial sepsis by attenuating systemic inflammation.
Csóka B; Németh ZH; Törő G; Koscsó B; Kókai E; Robson SC; Enjyoji K; Rolandelli RH; Erdélyi K; Pacher P; Haskó G
FASEB J; 2015 Jan; 29(1):25-36. PubMed ID: 25318479
[TBL] [Abstract][Full Text] [Related]
20. Purinergic Signaling as a Regulator of Th17 Cell Plasticity.
Fernández D; Flores-Santibáñez F; Neira J; Osorio-Barrios F; Tejón G; Nuñez S; Hidalgo Y; Fuenzalida MJ; Meza D; Ureta G; Lladser A; Pacheco R; Acuña-Castillo C; Guixé V; Quintana FJ; Bono MR; Rosemblatt M; Sauma D
PLoS One; 2016; 11(6):e0157889. PubMed ID: 27322617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
